H.R. 5629 · 119th Congress
To provide that the final rule of the Department of Health and Human Services titled "Medications for the…
Full title
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
R
HouchinSponsorNo cosponsors.
This bill nullifies part of the final rule issued by the Department of Health and Human Services (HHS) titled Medications for the Treatment of Opioid Use Disorder and published on February 2, 2024.
What it does: CRS summary · Introduced in House · Sep 30, 2025
This bill nullifies part of the final rule issued by the Department of Health and Human Services (HHS) titled Medications for the Treatment of Opioid Use Disorder and published on February 2, 2024.
The rule incorporated into regulations certain flexibilities for opioid treatment that were initially implemented during the COVID-19 public health emergency. The bill nullifies these flexibilities, including (1) expanded flexibility for patients in their first or second month of treatment to receive take-home doses of methadone, (2) flexibility to use telehealth examinations to admit patients for treatment involving buprenorphine or methadone, and (3) expanded access to evidence-based practices such as splitting doses for certain patients.
Pursuant to a statutory requirement, the rule also allowed patients to be admitted to an opioid treatment program without having to show at least a one-year history of opioid misuse. The bill nullifies these provisions of the rule.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Latest action (Sep 30, 2025): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Sep 30, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.